During the past decade, Hospital Universiti Sains Malaysia [Neurology] conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universiti Sains Malaysia [Neurology]" #1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universiti Sains Malaysia [Neurology]" are "Gastric Cancer" (2 trials), "NMO Spectrum Disorder (NMOSD)" (1 trials) and "Neuromyelitis Optica (NMO)" (1 trials). Many other conditions were trialed in "Hospital Universiti Sains Malaysia [Neurology]" in a lesser frequency.

Most popular intervention types in "Hospital Universiti Sains Malaysia [Neurology]" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "5-Fluorouracil" (2 trials), "Capecitabine" (1 trials), "Cisplatin" (1 trials) and "Ipatasertib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universiti Sains Malaysia [Neurology]" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Universiti Sains Malaysia [Neurology]". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Hospital Universiti Sains Malaysia [Neurology], undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universiti Sains Malaysia [Neurology], 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".